Ivan Bergstein
2016
In 2016, Ivan Bergstein earned a total compensation of $3.4M as President and Chief Executive Officer at Stemline Therapeutics, a 6% decrease compared to previous year.
Compensation breakdown
| Bonus | $401,709 |
|---|---|
| Option Awards | $1,769,653 |
| Salary | $535,613 |
| Stock Awards | $733,702 |
| Total | $3,440,677 |
Bergstein received $1.8M in option awards, accounting for 51% of the total pay in 2016.
Bergstein also received $401.7K in bonus, $535.6K in salary and $733.7K in stock awards.
Rankings
In 2016, Ivan Bergstein's compensation ranked 2,702nd out of 14,075 executives tracked by ExecPay. In other words, Bergstein earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,702 out of 14,075 | 81st |
Division Manufacturing | 928 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 271 out of 1,895 | 86th |
Industry group Drugs | 197 out of 1,538 | 87th |
Industry Pharmaceutical Preparations | 150 out of 1,176 | 87th |
Source: SEC filing on May 1, 2017.
Bergstein's colleagues
We found two more compensation records of executives who worked with Ivan Bergstein at Stemline Therapeutics in 2016.